You are here: Home > News & Events

News & Events

IDIBAPS hosts the meeting of the HEP-CAR european project on hepatocarcinoma and co-morbidities.

07/04/2017

On 13 March, IDIBAPS hosted the annual meeting of the European HEP-CAR consortium. The aim of the project is to identify the molecular mechanisms involved in the development of hepatocellular carcinoma (HCC) and their role in the different co-morbidities that induce the onset of this type of cancer: the infection by hepatitis B and C viruses, alcohol intake or obesity. 

The ‘Handbook of Translational Medicine’ is available now

The ‘Handbook of Translational Medicine’ is available now. Edited by Prof Josep M Llovet in collaboration with other teachers from the official Master in Translational Medicine (University of Barcelona).

IDIBAPS researchers identify a new therapeutic target for liver cancer

In the study, published in the Gastroenterology journal, they have found that this alteration occurs in 15% of tumors and that a monoclonal antibody can effectively block it and slow tumor progression in animal models. Dr. Josep M. Llovet, ICREA Professor, Head of the Translational research in hepatic oncology IDIBAPS group and Director of the Mount Sinai Liver Cancer Program at Icahn School of Medicine at Mount Sinai (New York), has coordinated this study. The first authors of the article are Iris Martínez-Quetglas and Roser Pinyol, researchers at the same team.

Prof Llovet has been elected Vice-Chair of the AASLD Hepatobiliary Neoplasia SIG.

 Prof Llovet has been elected Vice-Chair of the AASLD Hepatobiliary Neoplasia SIG. His 2 year term will begin on January 1st, 2017 until December 31st, 2018 and then he will move into the Chair role for 2 years beginning January 1st, 2019 until December 31st, 2020. 

Four researchers at Hospital Clínic and IDIBAPS among the 2015 most cited scientists

Thomson Reuters lists the 3000 most important names of 21 fields in science and social sciences. There have been evaluated articles published in indexed journals in these fields between 2003 and 2013 and there have only been considered those that rank in the top 1% by citations for field and year indexed in the Web of Science, the so called Highly Cited Papers. Thus, the fact of belonging to this classification means that the work of these researchers is considered particularly important among his colleagues.

More news

Events

EASL 2014

Wednesday, 04/09/2014

London, UK

Heptromic final meeting

Tuesday, 04/08/2014

Barcelona

Prof Josep M Llovet

Project led by: Idibaps

Copyright © 2010 - 2017 HEPTROMIC

HEPTROMIC is a project in the 'Health' Theme of the Specific Programme 'Cooperation' of the European Commission's Seventh Framework Programme.